Introduction: Novel nicotine delivery systems represent an evolving part of the tobacco harm reduction strategy. The pharmacokinetic (PK) profile of nicotine delivered by P3L, a pulmonary nicotine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback